.JPG)
Eli Lilly and Company, a pharmaceutical company that uses science to improve lives globally, has revealed that the Medicines and Healthcare products Regulatory Agency (MHRA) has approved the marketing of donanemab, an injection for intravenous...
BSV, Bharat Serums and Vaccines Ltd, has created innovative biologic products internally, showcasing their impressive research and development skills. They have a diverse collection of branded products in women's health, fertility, critical care...
Oblique Therapeutics, a top biotech company focused on creating new drugs, has partnered with Eli Lilly and Company (Lilly) to use the AbiProt technology in developing antibodies for a valuable target. This collaboration is designed to speed up...
Find Therapeutics, a biopharmaceutical company in the clinical stage, has started administering doses of FTX-101 in its phase 1 clinical trial involving healthy participants. FTX-101 is a novel therapeutic peptide that controls the Plexin...
Zydus Lifesciences announced that their typhoid vaccine ZyVac TCV has been granted preliminary acceptance by the World Health Organisation (WHO). The WHO's pre-qualification will allow United Nations (UN) agencies to buy ZyVac TCV. ZyVac TCV is...
Angelini Pharma, a division of Angelini Industries, and Cureverse Inc., a startup company, revealed they have signed a unique worldwide option contract to develop and market Cureverse's groundbreaking brain health asset CV-01. According to the...
Thermo Fisher Scientific, the global leader in scientific services, has been granted FDA approval for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic to select patients suitable for treatment with Servier Pharmaceuticals, LLC’s...
Ionis Pharmaceuticals, Inc. revealed that the Committee for Medicinal Products for Human Use (CHMP) in the European Union (EU) has recommended the approval of Ionis' and AstraZeneca's Wainzua (eplontersen) for treating hereditary transthyretin...
Oculis Holding AG (Oculis) has sped up the enrollment of patients for the phase 3 DIAMOND clinical trials of OCS-01 eye drops in DME and expanded the DIAMOND programme committees with leading retina specialists worldwide. Significant advancement...
The anti-diabetes market has tripled to almost Rs 17,000 crore, and the cardiac market has more than doubled to nearly Rs 30,000 crore from its 2014 levels of Rs 5,000 crore and Rs 10,000 crore, respectively. Sheetal Sapale, vice president of...
, CDSCO.jpg)
.jpg)